Fonarow, G. C., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Grau-Sepulveda, M. V., … Schwamm, L. H. (2011). Relationship between Door-to-Needle Times for Tissue Plasminogen Activator and In-Hospital Clinical Outcomes in Acute Ischemic Stroke. In STROKE (Vol. 42, pp. E86–E87). Los Angeles, CA: LIPPINCOTT WILLIAMS & WILKINS.

Fonarow, Gregg C., Eric E. Smith, Jeffrey L. Saver, Mathew J. Reeves, Deepak L. Bhatt, Maria V. Grau-Sepulveda, DaiWai M. Olson, Adrian F. Hernandez, Eric D. Peterson, and Lee H. Schwamm. “Relationship between Door-to-Needle Times for Tissue Plasminogen Activator and In-Hospital Clinical Outcomes in Acute Ischemic Stroke.” In STROKE, 42:E86–87. LIPPINCOTT WILLIAMS & WILKINS, 2011.

Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, et al. Relationship between Door-to-Needle Times for Tissue Plasminogen Activator and In-Hospital Clinical Outcomes in Acute Ischemic Stroke. In: STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2011. p. E86–7.

Fonarow, Gregg C., et al. “Relationship between Door-to-Needle Times for Tissue Plasminogen Activator and In-Hospital Clinical Outcomes in Acute Ischemic Stroke.” STROKE, vol. 42, no. 3, LIPPINCOTT WILLIAMS & WILKINS, 2011, pp. E86–87.

Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Relationship between Door-to-Needle Times for Tissue Plasminogen Activator and In-Hospital Clinical Outcomes in Acute Ischemic Stroke. STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2011. p. E86–E87.